Clinical Trial Update: Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics of single intravenous doses of peginesatide in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• OMontys (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Anemia, Chronic Kidney Disease | Phase 1 | Status: COMPLETED